These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36426655)

  • 1. Prenatal and fetal diagnosis of trisomy 18 after low-risk cell-free fetal DNA screening: A report of four cases.
    Sheehan E; Bacon V; Lascurain S; Stone J; Yatsenko S; Aarabi M; Skvarca LB; Clemens M; Saller D
    Prenat Diagn; 2023 Jan; 43(1):36-41. PubMed ID: 36426655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massively Parallel Sequencing (MPS) of Cell-Free Fetal DNA (cffDNA) for Trisomies 21, 18, and 13 in Twin Pregnancies.
    Du E; Feng C; Cao Y; Yao Y; Lu J; Zhang Y
    Twin Res Hum Genet; 2017 Jun; 20(3):242-249. PubMed ID: 28485265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of semiconductor sequencing platform for non-invasive prenatal genetic screening for fetal aneuploidy: results from a multicenter prospective cohort study in a clinical setting.
    El Khattabi LA; Brun S; Gueguen P; Chatron N; Guichoux E; Schutz S; Nectoux J; Sorlin A; Quere M; Boudjarane J; Tsatsaris V; Mandelbrot L; Schluth-Bolard C; Dupont JM; Rooryck C;
    Ultrasound Obstet Gynecol; 2019 Aug; 54(2):246-254. PubMed ID: 30191619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies.
    Rose NC; Barrie ES; Malinowski J; Jenkins GP; McClain MR; LaGrave D; Leung ML;
    Genet Med; 2022 Jul; 24(7):1379-1391. PubMed ID: 35608568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of fetal chromosomal aneuploidy diseases using noninvasive prenatal testing in twin pregnancies.
    Yu W; Lv Y; Yin S; Liu H; Li X; Liang B; Kong L; Liu C
    Expert Rev Mol Diagn; 2019 Feb; 19(2):189-196. PubMed ID: 30582381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of non-invasive prenatal testing in preventing birth defects].
    Zhang W; Li S; Tang P; Wang J; Gu S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1061-1064. PubMed ID: 32924101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic outcomes following a failed cell-free DNA screen: a population-based retrospective cohort study of 35,146 singleton pregnancies.
    Bellai-Dussault K; Meng L; Howley H; Reszel J; Huang T; Lanes A; Walker MC; Okun N; Dougan SD; Armour CM
    Am J Obstet Gynecol; 2023 Aug; 229(2):168.e1-168.e8. PubMed ID: 36627072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.
    Dar P; Jacobsson B; MacPherson C; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Edwards L; Haeri S; Silver R; Vohra N; Hyett J; Clunie G; Demko Z; Martin K; Rabinowitz M; Flood K; Carlsson Y; Doulaveris G; Malone C; Hallingstrom M; Klugman S; Clifton R; Kao C; Hakonarson H; Norton ME
    Am J Obstet Gynecol; 2022 Aug; 227(2):259.e1-259.e14. PubMed ID: 35085538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cell-free DNA in a consecutive series of 13,607 routine cases for the detection of fetal chromosomal aneuploidies in a single center in Germany.
    Borth H; Teubert A; Glaubitz R; Knippenberg S; Kutur N; Winkler T; Eiben B
    Arch Gynecol Obstet; 2021 Jun; 303(6):1407-1414. PubMed ID: 33151425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort study.
    Dugoff L; Koelper NC; Chasen ST; Russo ML; Roman AS; Limaye MA; Ranzini AC; Clifford CM; Biggio JR; Subramaniam A; Seasely A; Patil AS; Weed S; Page JM; Nicholas S; Idler J; Rao RR; Crowder A; Shree R; McLennan G; Bromley B
    Am J Obstet Gynecol; 2023 Oct; 229(4):435.e1-435.e7. PubMed ID: 37030426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.
    Gormus U; Chaubey A; Shenoy S; Wong YW; Chan LY; Choo BP; Oraha L; Gousseva A; Persson F; Prensky L; Chin E; Hegde M
    Curr Issues Mol Biol; 2021 Aug; 43(2):958-964. PubMed ID: 34449543
    [No Abstract]   [Full Text] [Related]  

  • 15. A gradual change of chromosome mosaicism from placenta to fetus leading to T18 false negative result by NIPS.
    Wang Z; Tang X; Yang S; Yin T; Zhao Y; Zheng A; Zhang R; Gu Y; Wang L
    Clin Chim Acta; 2019 Aug; 495():263-268. PubMed ID: 30998911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Cell-Free DNA Screening for Fetal Common Aneuploidies and Sex Chromosomal Abnormalities: A Prospective Study from a Less Developed Autonomous Region in Mainland China.
    Lai Y; Zhu X; He S; Dong Z; Tang Y; Xu F; Chen Y; Meng L; Tao Y; Yi S; Su J; Huang H; Luo J; Leung TY; Wei H
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33806256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of non-invasive prenatal screening detection in fetal chromosome aneuploidy].
    Cai AJ; Zhu CF; Xue SW; Cui SY; Qu SZ; Liu N; Kong XD
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):765-769. PubMed ID: 29179272
    [No Abstract]   [Full Text] [Related]  

  • 18. Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism.
    Hall AL; Drendel HM; Verbrugge JL; Reese AM; Schumacher KL; Griffith CB; Weaver DD; Abernathy MP; Litton CG; Vance GH
    Genet Med; 2013 Sep; 15(9):729-32. PubMed ID: 23492874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free DNA screening for aneuploidies in 7113 pregnancies: single Italian centre study.
    Mesoraca A; Margiotti K; Dello Russo C; Cesta A; Cima A; Longo SA; Barone MA; Viola A; Sparacino D; Giorlandino C
    Genet Res (Camb); 2020 Jun; 102():e5. PubMed ID: 32539871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.